CytoDynSTU:296 +3.13%28 Days Inventory is 0.00 as of Feb. 2026. GuruFocus rates STU:296 with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 635 Biotechnology companies, CytoDyn ranks worse than 157480.16% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). CytoDyn's Average Total Inventories for the
three
months ended in Feb. 2026 was €0.00 Mil. CytoDyn's Cost of Goods Sold for the
three
months ended in Feb. 2026 was €0.00 Mil.
The historical rank and industry rank for CytoDyn's Days Inventory or its related term are showing as below:
During the past 13 years, CytoDyn's highest Days Inventory was 643770.47. The lowest was 643770.47. And the median was 643770.47.
STU:296's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.23 * Ranked among companies with meaningful Days Inventory only.
CytoDyn's Days Inventory
stayed the same
from Feb. 2025 (0.00) to Feb. 2026 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CytoDyn (STU:296) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
CytoDyn's Inventory Turnover for the
three
months ended in Feb. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CytoDyn's Inventory to Revenue for the
three
months ended in Feb. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
CytoDyn Days Inventory Related Terms
CytoDyn Days Inventory Historical Data
* Premium members only.
The historical data trend for CytoDyn's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:296 vs VSTM, IRD, PALI: Days Inventory Comparison
For the Biotechnology subindustry, CytoDyn's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CytoDyn Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CytoDyn's Days Inventory distribution charts can be found below:
* The bar in red indicates where CytoDyn's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CytoDyn (STU:296) has a Days Inventory of 0.00 as of Feb. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CytoDyn and its competitors. Over the past decade, CytoDyn's Days Inventory has ranged from 643,770.47 to 643,770.47. According to the industry distribution chart, CytoDyn ranks #999999 out of 635 companies in the Biotechnology industry.
Is CytoDyn's Days Inventory too high?
CytoDyn's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 643,770.47 to a high of 643,770.47. Based on the distribution chart, CytoDyn ranks #999999 out of 635 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CytoDyn has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does CytoDyn's Days Inventory compare to VSTM and IRD?
According to the Biotechnology industry distribution chart, CytoDyn ranks #999999 out of 635 companies for Days Inventory. This places CytoDyn in the lower half of its industry. The industry median Days Inventory is 183.23. Historically, CytoDyn's own Days Inventory has ranged from 643,770.47 to 643,770.47 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CytoDyn and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CytoDyn's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CytoDyn stock overvalued right now?
CytoDyn (STU:296) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. CytoDyn's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For CytoDyn (STU:296), the current Days Inventory is 0.00 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CytoDyn Inc is a USA-based clinical-stage biotechnology company that focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The product candidate is PRO 140, which is a class of HIV therapy called entry inhibitors that block HIV from entering into and infecting certain cells. The company emphasizes exploring opportunities for clinical applications for PRO 140 involving the CCR5 (C-C chemokine receptor type 5) receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases, and cancer.
28GF Score
Get the complete analysis for STU:296
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:296 has been successfully added to your 
